Venturi Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.61M | Sell |
5,871
-34
| -0.6% | -$15.1K | 0.13% | 98 |
|
|
2025
Q1 | $2.86M | Sell |
5,905
-207
| -3% | -$100K | 0.15% | 84 |
|
|
2024
Q4 | $2.46M | Buy |
6,112
+3,580
| +141% | +$1.44M | 0.12% | 105 |
|
|
2024
Q3 | $1.18M | Buy |
2,532
+40
| +2% | +$18.6K | 0.06% | 172 |
|
|
2024
Q2 | $1.17M | Buy |
2,492
+190
| +8% | +$89.1K | 0.07% | 163 |
|
|
2024
Q1 | $962K | Buy |
2,302
+9
| +0.4% | +$3.76K | 0.06% | 189 |
|
|
2023
Q4 | $933K | Buy |
2,293
+24
| +1% | +$9.77K | 0.07% | 181 |
|
|
2023
Q3 | $789K | Buy |
2,269
+82
| +4% | +$28.5K | 0.06% | 191 |
|
|
2023
Q2 | $770K | Sell |
2,187
-6
| -0.3% | -$2.11K | 0.06% | 186 |
|
|
2023
Q1 | $691K | Sell |
2,193
-215
| -9% | -$67.7K | 0.06% | 207 |
|
|
2022
Q4 | $695K | Buy |
2,408
+239
| +11% | +$69K | 0.06% | 209 |
|
|
2022
Q3 | $628K | Buy |
2,169
+207
| +11% | +$59.9K | 0.06% | 205 |
|
|
2022
Q2 | $553K | Sell |
1,962
-570
| -23% | -$161K | 0.05% | 218 |
|
|
2022
Q1 | $661K | Buy |
2,532
+782
| +45% | +$204K | 0.05% | 216 |
|
|
2021
Q4 | $384K | Sell |
1,750
-34
| -2% | -$7.46K | 0.03% | 267 |
|
|
2021
Q3 | $324K | Buy |
+1,784
| New | +$324K | 0.03% | 264 |
|
|
2019
Q1 | – | Sell |
-1,704
| Closed | -$279K | – | 272 |
|
|
2018
Q4 | $279K | Buy |
+1,704
| New | +$279K | 0.05% | 217 |
|